Patent Strategy

Different organisations require different strategies

Startups

For a startup, patent strategy is often an exercise in preserving valuable options while managing limited resources.

The objective is not necessarily to build a large portfolio. It is to establish a defensible position around the technology that creates commercial value, while retaining sufficient flexibility for the company to develop, raise investment and enter new markets.

A startup strategy may address:

• identifying the inventions that protect the company’s genuine competitive advantage;
• choosing between patent protection and trade secrecy;
• coordinating patent filings with product launches, investor presentations and public disclosures;
• preparing an initial application broad enough to accommodate foreseeable technical developments;
• using the priority year to generate additional data and refine commercial plans;
• determining whether a PCT application provides useful time for investment, licensing or market validation;
• aligning national-phase expenditure with financing milestones;
• concentrating resources on one or more commercially meaningful patent families;
• ensuring that rights created by founders, employees and consultants are properly assigned; and
• preparing the portfolio for investor or transaction due diligence.

For a startup, a well-designed patent family may be more valuable than a larger collection of filings that lacks a clear commercial purpose.

Universities and research institutions

Universities operate at the intersection of research, publication, collaboration and commercialisation.

A patent strategy must therefore consider not only patentability, but also academic disclosure, institutional ownership, research funding, industrial partnerships and the prospects of technology transfer.

Relevant decisions may include:

• filing before publication, conference presentation or thesis disclosure;
• identifying inventorship and ownership across departments and collaborating institutions;
• reviewing funding conditions and university–industry agreements;
• distinguishing a patentable invention from a scientifically valuable research result;
• assessing whether sufficient technical evidence exists to support meaningful patent protection;
• testing commercial and licensing interest during the priority year;
• deciding whether PCT protection is justified before substantial international costs arise;
• selecting countries according to realistic licensing or spin-off opportunities;
• structuring licences for established businesses or newly created spin-offs; and
• determining how prosecution and maintenance costs will be allocated.

Not every scientifically important result requires international patent protection. The relevant question is whether the proposed rights can support a credible route to development, licensing or commercial application.

Corporate patent portfolios

For an established company, the challenge is often not the absence of patents, but the complexity of the portfolio.

Corporate patent strategy requires continuing coordination between research and development, product management, commercial teams, finance and legal functions. Each patent family should have an identifiable role within the business.

A corporate strategy may include:

• evaluating and prioritising invention disclosures;
• mapping patent families to products, technologies and business units;
• distinguishing core, defensive, blocking and licensing assets;
• identifying overlapping or redundant protection;
• monitoring competitors and adjacent technology areas;
• coordinating PCT entries with sales, manufacturing and enforcement priorities;
• maintaining future claim options through divisional or related applications;
• reviewing opposition, revocation and enforcement exposure;
• choosing between unitary protection and national validation;
• conducting structured reviews before renewal-fee decisions; and
• identifying patents that should be retained, licensed, sold or allowed to lapse.

A successful portfolio is not measured solely by the number of patents it contains. Its strength depends on how effectively those rights support products, markets and strategic choices.

Every stage creates a decision point

Patent strategy evolves throughout the life of a technology. Each procedural deadline is also an opportunity to reconsider the commercial assumptions behind the filing.

Before filing

The first decision is not where to file, but whether filing is the right form of protection.

We consider:

• the commercial function of the invention;
• whether infringement can realistically be detected;
• whether the technology could be kept confidential;
• the risk of independent development or reverse engineering;
• ownership and inventorship;
• the available technical evidence;
• planned disclosures and product launches; and
• the relationship between the invention and the wider product architecture.

First filing and the priority year

The first application should support both the current invention and its reasonably foreseeable development.

During the priority year, the strategy may be refined using:

• new experimental or technical results;
• patentability-search findings;
• product-development decisions;
• investor and partner feedback;
• competitor activity;
• changes in the commercial model; and
• newly identified variations or applications.

Where necessary, additional applications may be used to protect developments that were not adequately disclosed in the original filing.

PCT strategy

A PCT application is not a worldwide patent. It is a mechanism for preserving international options while postponing many national and regional filing decisions.

A PCT application buys time and information—not countries.

The value of a PCT application depends on what the organisation expects to learn or achieve during the international phase. This may include obtaining search results, completing technical development, identifying partners, raising investment or determining which markets are commercially viable.

Before national or regional phase entry, we assess:

• present and expected markets;
• manufacturing and supply-chain locations;
• competitor activities;
• importation and distribution routes;
• the practical detectability of infringement;
• enforcement conditions;
• licensing opportunities;
• the expected product-launch date;
• the remaining commercial life of the technology; and
• the full cost of prosecution and maintenance.

The appropriate PCT-entry strategy may therefore be different for every organisation. A startup may concentrate its resources on a small number of investment-critical territories. A university may follow the likely markets of a prospective licensee. A multinational business may protect not only its sales markets but also the principal manufacturing locations of its competitors.

Examination and claim strategy

The objective of examination is not merely to obtain a granted patent. It is to obtain claims that perform a meaningful commercial function.

Strategic decisions may include:

• whether broader claims justify further argument or amendment;
• whether faster grant is more valuable than continued pursuit of broader scope;
• whether a divisional application should preserve a distinct invention or commercial embodiment;
• whether different claim categories improve enforcement options;
• how amendments may affect validity and interpretation; and
• whether the resulting claims cover activities that can be identified and proved.

A quickly granted but commercially irrelevant patent may be less useful than a carefully developed claim set aligned with the product and the market.

Grant, validation and unitary protection

The grant of a European patent creates a further strategic decision: where and in what form should protection continue?

A Unitary Patent may provide broad territorial coverage and centralised administration. However, it also creates a single territorial package that cannot later be reduced one country at a time merely to manage renewal expenditure.

Traditional national validations may be preferable where the business wishes to:

• retain protection only in selected markets;
• adjust the geographical portfolio over time;
• discontinue individual countries as commercial priorities change;
• distribute certain enforcement or revocation risks; or
• develop different national licensing strategies.

Unitary protection may be attractive where long-term protection across most participating states is commercially justified and the benefits of central administration and enforcement outweigh the need for country-by-country flexibility.

The same analysis will not produce the same answer for every patent. A pharmaceutical product, an industrial component and a short-cycle digital technology may require very different territorial structures.

Renewal, refocus, license or let go

Every renewal-fee deadline is a new investment decision.

A patent should not be maintained merely because it was maintained in the preceding year. The relevant considerations may include:

• whether the protected technology is still used;
• present and expected revenue;
• the activities of competitors;
• the remaining patent term;
• the strength and practical relevance of the claims;
• the ability to detect infringement;
• the existence of overlapping patent families;
• potential licensing or sale opportunities;
• pending regulatory or technical milestones; and
• the cost of maintaining protection in each territory.

Some rights should be retained. Others may be narrowed geographically, licensed, transferred or allowed to lapse. The purpose of portfolio review is to direct resources towards the rights that continue to create strategic value.

Strategy under uncertainty

Patent decisions frequently have to be made before the commercial outcome of a technology is known.

We therefore consider not only the current value of a patent, but also the future choices that it preserves. A filing, a PCT application or a divisional application may create value by keeping an important option open until better technical or commercial information becomes available.

Our analysis may draw on:

• decision trees and alternative scenarios;
• legal, technical and commercial risk factors;
• the patent’s position within the surrounding rights landscape;
• expected economic benefits;
• comparable technologies and transactions;
• the cost of reasonable alternatives;
• future development and licensing opportunities; and
• the quality of the assumptions on which the decision depends.

Patent valuation is not treated as a single precise figure. It is used as a decision framework: how much should be invested, what information is still required, and which future options justify being preserved?

From patent count to portfolio intelligence

We examine each patent or patent family as a combination of legal, technical and commercial elements.

This may include:

• scope and quality of the claims;
• remaining term;
• ownership and contractual restrictions;
• coverage of current and future products;
• availability of design-around alternatives;
• relevance to competitors;
• enforceability and infringement visibility;
• geographical coverage;
• licensing potential;
• interaction with related patents, trade secrets and regulatory rights; and
• the future decisions preserved by pending applications.

This approach makes it possible to move beyond patent counting and towards a portfolio in which each right has a defined strategic role.

Our strategic approach

Depending on the organisation and the stage of the portfolio, our work may include:

• invention and portfolio workshops;
• filing and priority strategies;
• patent-versus-trade-secret assessments;
• PCT and national-phase planning;
• market and competitor-oriented country selection;
• Unitary Patent and national-validation analysis;
• claim and divisional strategy;
• annual portfolio reviews;
• renewal and abandonment recommendations;
• licensing and transaction preparation; and
• decision frameworks for startups, universities and corporate IP teams.

The result is not a static filing plan. It is a strategy designed to evolve as the technology, market, budget and organisation evolve.

Build a portfolio that can adapt

The central question is not simply where a patent can be filed.

It is what the right must achieve, which future options should remain open, and how available resources can be directed towards the protection that matters most.

Discuss your patent strategy with Stan Advoka.
info@stanadvoka.com